This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 2, 2012







 



FDA: Beware of fake online pharmacies
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A national campaign aimed at making Americans more aware of the prevalence of fake online pharmacies has been launched by the Food and Drug Administration. The FDA warned that fraudulent online pharmacies pose a danger to patient health. The agency says it aims to help consumers make safe purchases. More



 Area and Association News


AzPA Fall Pharmacy Conference
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
You could win $500 playing the Know Pain, Know Gain NASPA Pain Management Challenge. Attend the AzPA Fall Pharmacy Conference on Oct. 20. More

Medicase

A safe and convenient compliance package to help your patients take their daily medications, wherever they may be.

MediCase requires no expansive heat sealing equipment and it is easily and quickly assembled in your pharmacy to the patient's specific needs.

For more information on Medicase or our other medication compliance products, visit www.crocusmed.com or contact
Diane LaTourelle: dlatourelle@crocusmed.com


Flu vaccine roundup
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Arizona HAI Advisory Committee is partnering with the Grand Canyon Chapter of the Association for Infection Preventionists (APIC) to support Arizona Infection Prevention Week (IPW). The goal of 2012 Arizona IPW is to heighten awareness of the need to protect everyone from infections. On Wednesday, Oct. 17, we will be tracking the number of vaccines administered to the public to beat last year's statewide influenza vaccine record. Learn more.

American Pharmacists Month 2012
American Pharmacists Association    Share    Share on FacebookTwitterShare on LinkedinE-mail article
October is American Pharmacists Month. Visit the APhA website for ways to celebrate in your practice setting.

The #1 Selling Brain Health Supplement in Drug Stores Nationally.
As we age we lose calcium-binding proteins that protect our brain cells. This protein loss affects our ability to learn, retain memories, think and concentrate.* Prevagen® (apoaequorin) replaces these proteins in the body and helps protect our cells during this natural process of aging.*


Pharmacy-Based Immunization Services Certificate Training Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Date: Monday, Nov. 12
Space limited to 20 registrants. Click to register.


Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates


Pharmacist apologizes after accidental methadone prescription nearly kills boy
WPIX-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The family of a 7-year-old is suing, after he almost died when a drug mix-up by his pharmacy left him accidentally overdosed on the wrong medication. The pharmacist's mea culpa may not be nearly enough to avoid legal action and the threat of losing his license. "He wasn't breathing. He was just blue," Christina Torres said about her son after giving him what she thought was Ritalin. The reason for his grave state was that she had given her son another drug entirely, one meant to treat hard-core drug abusers — methadone. More

Walgreen's new battle: Winning back Express Scripts customers
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Walgreen, closing the books on a "challenging" fiscal 2012, admitted to investors that regaining customers lost from its contract dispute with Express Scripts is going to be a tough sled. Recently, Walgreen chief executive officer Gregory Wasson wouldn't disclose specifics or predict the number of customers and prescriptions that would return to the nation's largest drug store chain even though Walgreen renewed its relationship with Express Scripts. More

CVS Caremark survey: Pharmacists say cost is biggest barrier to Rx adherence
Drug Store News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In recognition of American Pharmacists Month in October, CVS Caremark released results from a new survey of CVS retail pharmacists, which underscored that cost remains a key barrier to medication adherence and reinforced the important role of the pharmacist in helping people take their chronic medications as directed. While there are many reasons people stop taking their medications, the majority of pharmacists surveyed — 62 percent — said that the high cost of drugs currently is the biggest cause of nonadherence for their patients. More

 In the News


Study: Children underrepresented in clinical drug trials
HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drug studies enrolling adults far outnumber clinical trials involving children, and the scope of research on children is also more limited than it is for adults, new research from Duke University finds. This puts children and their physicians at a significant disadvantage, the researchers concluded. More

Survey: More and more pharmacy patients can't get satisfaction through mail order
Drug Store News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study." "The erosion in customer satisfaction with mail-order pharmacies may foretell challenges to their business model, as prior to 2011, customer satisfaction was more equivalent to the brick-and-mortar experience," stated Rick Millard, senior director of the healthcare practice at J.D. Power and Associates. More

Making the 'pharmacy crawl'
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Robin Haas used to visit just one pharmacy a month to get the painkillers she needs to relieve the chronic aching in her injured neck and back. Now the 40-year-old resident of North Port, Fla., has to crisscross five towns, making at least 30 visits to a half-dozen pharmacies every month to get her prescriptions filled. Many pharmacies in the state have curbed their supplies of the so-called opioid drugs and put new restrictions on dispensing them in the face of a government crackdown on painkiller abuse. More

Novel drug approach shows promise against breast cancer
HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer treatment could one day be more effective and less difficult to endure if an experimental breast cancer therapy that offers high-precision targeting of tumors proves successful. The new approach uses a unique three-pronged combination of agents that simultaneously attack cancer cells but prevent the release of chemotherapy until the drug reaches its specific target, said the authors of a new study on the technique. More

 FDA News


Sanofi Pasteur recalls typhoid fever vaccine
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Sanofi Pasteur Inc. recently started a recall of six lots of its typhoid Vi polysaccharide vaccine, Typhim Vi, because they are "at risk for lower antigen content," according to a notice posted by the Food and Drug Administration. There may be still be usable Typhim Vi syringes and vials in the supply chain, said company spokesman Len Lazenza. He called the current recall a partial one. More

FDA approves new colon cancer drug
MyHealthNewsDaily via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new drug has received fast-track approval to treat advanced colon cancer, the Food and Drug Administration announced. The drug, Stivarga, has been approved to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body, the FDA said. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Oct. 2, 2012
Sept. 25, 2012
Sept. 18, 2012
Sept. 11, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063